Setipiprant, CAS [[866460-33-5]]

Produktübersicht

• Artikelname: Setipiprant, CAS [[866460-33-5]]
• Artikelnummer: TGM-T3520
• Hersteller Artikelnummer: T3520
• Alternativnummer: TGM-T3520-1MLX10MM(INDMSO),TGM-T3520-10MG,TGM-T3520-25MG,TGM-T3520-50MG,TGM-T3520-100MG,TGM-T3520-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: KYTH-105 , ACT-129968

Produktbeschreibung

Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2, a G protein-coupled receptor for prostaglandin (PGD2), mediates key inflammatory responses related to allergy and asthma. PGD2, produced by mast cells, binds to CRTH2 on blood-borne cells, inducing chemotaxis of Th2 cells, basophils, and eosinophils, and stimulating cytokine release.

Produkteigenschaften

• Molekulargewicht: 402.42
• Reinheit: 99.16%
• CAS Nummer: [866460-33-5]
• Formel: C24H19FN2O3
• Target-Kategorie: Prostaglandin Receptor|||GPCR

Bilder

T3520